Methods for diagnosis of Alzheimer's Disease in blood samples
US7598049B2 · kind B2 · utility
13Cited by
17References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 19, 2004 |
| Grant date | Oct 6, 2009 |
| Priority date | — |
| Expiry date | Nov 19, 2024 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2821
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The inventors have discovered a collection of proteinaceous biomarkers (“AD biomarkers) which can be measured in peripheral biological fluid samples to aid in the diagnosis of neurodegenerative disorders, particularly Alzheimer's disease and mild cognitive impairment (MCI). The invention further provides methods of identifying candidate agents for the treatment of Alzheimer's disease by testing prospective agents for activity in modulating AD biomarker levels.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.